Condition: Chronic hepatitis



DESCRIPTION: The hepatitis C virus inflicts most of its damage by latching onto molecules of iron and generating free-radical damage to liver cells. These free radicals can induce liver inflammation, cirrhosis, and primary liver cancer via oxidative attacks on liver cells. Successful eradication of the hepatitis C virus from the body often requires that iron levels in the liver and blood be at very low levels. In many cases, high stores of iron in the liver preclude successful therapy against the hepatitis C virus. It is desirable to reduce iron levels in the body before initiating treatment with conventional (interferon and ribavirin) therapy. Despite substantial scientific evidence, few physicians implement iron-depletion therapy when treating hepatitis C. This partially accounts for the high failure rate to eradicate the virus In patients with hepatitis C, particularly those who are HIV-positive, a systemic depletion of glutathione is present, especially in the liver. This depletion may be a factor underlying the resistance to interferon therapy. This finding represents a biological basis for taking supplements that boost cellular glutathione levels. Glutathione is a critical factor in protecting liver cells against free-radical damage.

Diseases Chronic hepatitis is associated with:

Hepititis C | Liver Disease |

Symptoms associated with Chronic hepatitis:

High liver enzymes | Jaundice | Lipid peroxidation | Yellow skin |

List of EAP product(s) which may assist with Chronic hepatitis :

ThioGel | ThioGel - L |




List of other EAP products:

OmniFlex | ThioGel | ThioGel - L |

 

Go back to RESOURCE HOME: Click here